Streetbeat News

IYH

iShares U.S. Healthcare ETF

https://www.ishares.com/us/products/239511/ishares-us-healthcare-etf

Industry

Asset Management

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the healthcare sector of the U.S. equity market. The fund is non-diversified.

Open

60.63

Mkt cap

3.1B

Volume

605K

High

61.17

P/E Ratio

32.40

52-wk high

66.59

Low

60.61

Div yield

0.01

52-wk low

57.38

The healthcare sector is overvalued by 12% compared to 11-year averages, with pharmaceuticals/biotechnology showing low value and quality scores. The iShares U.S. Healthcare ETF (IYH) has underperformed compared to XLV, which has lower fees and higher trading volume, making XLV a preferable choice for investors.

Portfolio Pulse from

January 20, 2025 | 11:00 am

The iShares U.S. Healthcare ETF (IYH) offers broad exposure to the U.S. healthcare sector and is a passively managed fund launched in 2000.

Portfolio Pulse from

December 04, 2024 | 12:30 pm

The CNBC Halftime Report highlighted final trades including The Walt Disney Company, ASHTEAD GROUP PLC, The Trade Desk, and iShares U.S. Healthcare ETF.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2024 | 5:02 pm

CNBC's 'Final Trades' highlighted Deere & Company, Amgen, iShares U.S. Healthcare ETF, and Copart. Analysts have adjusted price targets for Deere and Amgen, while Copart's recent earnings missed estimates. All mentioned stocks saw gains in Wednesday's session.

Portfolio Pulse from Avi Kapoor

October 10, 2024 | 12:49 pm

The CNBC Halftime Report highlighted final trades including Copart, Amgen, Deere & Company, and the iShares U.S. Healthcare ETF. These stocks and ETF were discussed as potential investment opportunities.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 5:02 pm

On CNBC's 'Halftime Report Final Trades,' analysts discussed AbbVie, Leidos, iShares U.S. Healthcare ETF, and KKR. AbbVie reported strong Q2 earnings, Leidos showed stable earnings with revenue growth, iShares U.S. Healthcare ETF was recommended, and KKR received a Buy rating with a raised price target.

Portfolio Pulse from Avi Kapoor

August 06, 2024 | 12:43 pm

The CNBC Halftime Report highlighted final trades including KKR & Co., Leidos Holdings, AbbVie, and the iShares U.S. Healthcare ETF. These stocks and ETF were discussed as potential investment opportunities.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 5:01 pm

Delta Air Lines, Interactive Brokers, and iShares ETFs were highlighted on CNBC's 'Final Trades.' Delta Air Lines faced a 3.5% drop due to flight cancellations and a cyber outage, despite beating sales estimates. Interactive Brokers saw a 1.4% gain after strong earnings. iShares U.S. Healthcare ETF and iShares MSCI India Small-Cap ETF also saw gains.

Portfolio Pulse from Avi Kapoor

July 23, 2024 | 1:08 pm

The CNBC Halftime Report's final trades include Interactive Brokers Group, Delta Air Lines, Ishares MSCI India Small Cap ETF, and IShares U.S. Healthcare ETF.

Portfolio Pulse from Benzinga Newsdesk

July 22, 2024 | 5:01 pm

Healthcare investors are anticipating that a potential Trump administration could ease regulations on Medicare Advantage, which may benefit health insurers like UnitedHealth, Cigna, and Humana. This expectation has led to mixed results in the health insurance sector, with some stocks rising and others falling. ETFs holding health insurer stocks have generally trended upward.

Portfolio Pulse from Michael Juliano

July 17, 2024 | 8:09 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.